Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 860M | 870M | 880M | 970M |
Cost of revenue | 310M | 400M | 380M | 400M |
Gross profit | 550M | 470M | 500M | 570M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 430M | 700M | 400M | 340M |
Other operating expenses | — | — | — | — |
Operating income | -250M | -590M | -260M | -160M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 110M | 110M | 110M | 120M |
Other income expense | — | — | — | — |
Pretax income | -730M | -560M | -290M | -210M |
Tax provision | 40M | 0 | 0 | 0 |
Net income | -25.0B | -23.8B | -22.9B | -22.2B |
Basic EPS | — | -8.7 | -8.3 | -8.1 |
Diluted EPS | — | -8.7 | -8.3 | -8.1 |
Basic average shares | — | 2.7B | 2.7B | 2.7B |
Diluted average shares | — | 2.7B | 2.7B | 2.7B |
EBITDA | 160M | -230M | 80M | 210M |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |